Chloromycetin: Potent Broad-Spectrum Antibiotic Therapy
Chloromycetin
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.87 | $52.00 (0%) | 🛒 Add to cart |
| 90 | $0.79 | $78.00 $71.00 (9%) | 🛒 Add to cart |
| 120 | $0.76 | $104.00 $91.00 (12%) | 🛒 Add to cart |
| 270 | $0.69 | $234.00 $185.00 (21%) | 🛒 Add to cart |
| 360 | $0.67
Best per pill | $312.00 $242.00 (22%) | 🛒 Add to cart |
Similar products
Chloromycetin (chloramphenicol) is a bacteriostatic antibiotic with a distinguished history in clinical practice, renowned for its efficacy against a wide range of gram-positive and gram-negative bacteria, as well as certain other microorganisms. It functions by inhibiting bacterial protein synthesis, specifically binding to the 50S ribosomal subunit, which prevents peptide bond formation. While its systemic use is now reserved for serious infections due to potential hematologic toxicity, its topical and ophthalmic formulations remain valuable tools in combating susceptible ocular and superficial bacterial infections. This agent is particularly critical in settings where newer antibiotics are unavailable or inappropriate, and it demands careful, knowledgeable administration under professional supervision.
Features
- Active ingredient: Chloramphenicol
- Available forms: Ophthalmic ointment, ophthalmic solution, topical cream, oral capsules, and intravenous formulation
- Mechanism: Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit
- Spectrum: Broad-spectrum activity against many gram-positive and gram-negative bacteria, rickettsiae, and some other pathogens
- Prescription status: Available by prescription only in most jurisdictions
Benefits
- Effective against a wide range of pathogenic bacteria, including many resistant strains
- Rapid penetration into tissues and body fluids, including the central nervous system
- Multiple formulation options allow for targeted treatment approaches
- Cost-effective alternative to newer antibiotics in appropriate clinical scenarios
- Well-established efficacy profile with decades of clinical use
- Particularly valuable for treating serious infections when other antibiotics are contraindicated or ineffective
Common use
Chloromycetin is primarily employed in the treatment of serious infections caused by susceptible organisms when less potentially toxic agents are ineffective or contraindicated. Systemic administration is reserved for life-threatening conditions such as typhoid fever, bacterial meningitis, rickettsial diseases, and other severe infections. Topical formulations are commonly used for superficial eye infections including bacterial conjunctivitis, blepharitis, and keratitis caused by susceptible organisms. The ophthalmic preparation is particularly valued for its ability to penetrate ocular tissues effectively. In some regions, it remains an important option for treating cholera and other enteric infections. The drug’s use requires careful consideration of the infection severity, susceptibility testing results, and available treatment alternatives.
Dosage and direction
Dosage varies significantly based on the formulation, infection severity, patient age, and renal/hepatic function. For systemic administration in adults, typical doses range from 50-100 mg/kg/day divided every 6 hours, not exceeding 4 g daily. Pediatric dosing requires careful weight-based calculation and monitoring. For ophthalmic use, apply 1-2 drops to the affected eye(s) every 3-6 hours, or a small amount of ointment into the conjunctival sac 3-4 times daily. Topical cream should be applied to affected areas 1-3 times daily. Treatment duration should be the shortest possible to achieve clinical cure, typically 7-14 days for systemic infections. Complete the full course even if symptoms improve earlier. Serum concentration monitoring is recommended during prolonged high-dose therapy.
Precautions
Chloromycetin requires extreme caution due to potential serious adverse effects. Hematologic monitoring is essential, with complete blood counts before therapy, every 2 days during therapy, and for several days after discontinuation. Use with particular caution in patients with hepatic or renal impairment, requiring dosage adjustment. Avoid unnecessary use and prolonged treatment courses. Patients should be advised to report immediately any signs of infection, unusual bleeding, bruising, or sore throat. Use during pregnancy only if clearly needed and potential benefits justify potential risks to the fetus. Breastfeeding should be discontinued during treatment due to secretion in breast milk. Superinfection by nonsusceptible organisms may occur.
Contraindications
Chloromycetin is contraindicated in patients with known hypersensitivity to chloramphenicol or any component of the formulation. It must not be used for trivial infections, as prophylaxis, or for infections treatable with other less dangerous antimicrobial agents. Contraindicated in patients with a history of chloramphenicol-induced blood dyscrasias. Avoid use in neonates due to the potential for “gray baby syndrome” caused by immature metabolic pathways. Not recommended for patients with pre-existing bone marrow depression or hematologic disorders. Concomitant use with drugs that suppress bone marrow function is generally contraindicated.
Possible side effect
The most serious adverse effect is bone marrow suppression, which may be dose-related and reversible or idiosyncratic and potentially fatal (aplastic anemia). Gastrointestinal effects include nausea, vomiting, diarrhea, and glossitis. Neurologic effects may include headache, mild depression, confusion, or optic neuritis with prolonged use. Hypersensitivity reactions ranging from rash to anaphylaxis may occur. “Gray baby syndrome” in neonates characterized by abdominal distension, cyanosis, vasomotor collapse, and death. Superinfections with nonsusceptible organisms including fungi may develop. Peripheral neuropathy has been reported with prolonged use. Ophthalmic preparations may cause transient burning, stinging, or blurred vision.
Drug interaction
Chloromycetin interacts significantly with numerous medications. It may inhibit the metabolism of warfarin, phenytoin, tolbutamide, and chlorpropamide, potentially increasing their effects and toxicity. Concurrent use with other bone marrow-suppressing agents (cytotoxic drugs, radiation therapy) increases hematologic toxicity risk. Barbiturates may reduce chloramphenicol concentrations by inducing hepatic enzymes. It may antagonize the bactericidal effects of penicillins and aminoglycosides in some situations. Concurrent administration with iron preparations, vitamin B12, or folic acid may mask developing hematologic toxicity. Use with caution alongside other hepatically metabolized drugs.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next scheduled dose. Do not double the dose to make up for a missed one. For ophthalmic preparations, apply the missed dose when remembered, then resume the regular schedule. Maintaining consistent blood levels is important for systemic infections, so patients should try to adhere strictly to the dosing schedule. If multiple doses are missed or the regimen is significantly disrupted, contact the prescribing healthcare provider for guidance. Document missed doses when monitoring treatment response.
Overdose
Chloramphenicol overdose constitutes a medical emergency requiring immediate attention. Symptoms may include nausea, vomiting, altered mental status, and the early signs of gray syndrome in susceptible patients (especially infants). Cardiovascular collapse may occur with massive overdoses. There is no specific antidote; treatment is supportive and symptomatic. Gastric lavage may be beneficial if performed soon after ingestion. Hemodialysis is not effective for removal due to high protein binding. Monitor hematologic parameters closely for several weeks after overdose. Supportive care including maintenance of fluid and electrolyte balance, and monitoring of vital signs is essential. Contact poison control center immediately for guidance.
Storage
Store at controlled room temperature (15-30°C or 59-86°F). Protect from light and moisture. Keep ophthalmic solutions and ointments tightly closed when not in use. Do not freeze any formulations. Keep all medications out of reach of children and pets. Do not use after the expiration date printed on the packaging. Discard any ophthalmic solution 28 days after opening. Do not store in bathroom cabinets where humidity and temperature fluctuations may degrade the product. For intravenous formulations, follow specific storage instructions provided by the manufacturer or pharmacy.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Chloromycetin is a potent antibiotic with serious potential side effects and must be used only under the supervision of a qualified healthcare professional. The prescribing physician will determine the appropriate use based on individual patient factors, infection characteristics, and local resistance patterns. Never self-medicate with chloramphenicol or share prescription medications. Always follow the specific instructions provided by your healthcare provider and pharmacist. Report any adverse effects immediately to your healthcare provider.
Reviews
“After developing bacterial meningitis during travel abroad, chloramphenicol was the only effective treatment available. While the monitoring requirements were rigorous, the drug successfully cleared the infection when other antibiotics failed.” - Infectious Disease Specialist, 15 years experience
“Our ophthalmology department continues to use chloramphenicol eye ointment for certain resistant conjunctivitis cases. Its broad spectrum and excellent ocular penetration make it valuable despite newer alternatives.” - Ophthalmologist, teaching hospital
“The hematologic risks associated with systemic chloramphenicol cannot be overstated. We reserve it for absolutely necessary cases with careful monitoring, but it remains irreplaceable for some multidrug-resistant infections.” - Clinical Pharmacologist
“While we’ve largely transitioned to newer antibiotics in developed settings, chloramphenicol remains essential in resource-limited areas for treating typhoid and other serious infections where alternatives are unavailable or unaffordable.” - Global Health Physician